“…When musing on how to achieve advances in the design of ligand analogs, the topological information gained by NMR experiments is conducive. In addition to blocking antibodies or lectins optimized ligands as oligosaccharides or glycomimetics may eventually find applications as clinically beneficial therapeutics in antiadhesion therapy to fight viral or bacterial infections, undesired inflammation or tumor spread, as illustrated in figure 11, or as targeting device in organ/cell type-selective drug delivery [Gabius, 1988[Gabius, , 1997b[Gabius, , 1998Karlsson, 1991;Colman, 1994;Grootenhuis et al, 1994;Gabius et al, 1995Gabius et al, , 1996Simon, 1996;Zopf and Roth, 1996;Cornejo et al, 1997;Lowe and Ward, 1997;Mahal and Bertozzi, 1997;Rice, 1997;Witczak, 1997].…”